Back

What we have learned from SGLT2i trials

23 May 2023 (10:00 - 10:15)
Organised by: Logo
Congress Presentation Part of: Obesity and HFpEF: a new phenotype? Chronic Heart Failure HFA Premium Access Heart Failure 2023 Heart Failure Association (HFA)

About the speaker

Photo
Professor Felipe Martinez

DAMIC Medical Institute, Cordoba (Argentina)

3 More presentations in this session

Presentation thumbnail
The obesity phenotype of HFpEF
Doctor T. Gorter (Groningen, NL)
Slides Video
Presentation thumbnail
GLP1 receptor analogues: the new frontier?
Slides Video
Presentation thumbnail
On the horizon: bariatric surgery and … life style!
Professor P. Agostoni (Milan, IT)
Slides Video

Access the full session

Session thumbnail
Obesity and HFpEF: a new phenotype?
Video

The Event

Event poster

Heart Failure 2023

23 May 2023 10:00 CET
You may be interested in
thumbnail
Congress Presentation
Optimal medical therapy in HFpEF patients with obesity
1 September 2024
thumbnail
Congress Presentation
SGLT2 inhibitors for obesity
31 August 2024
thumbnail
Congress Session
SGLT2 inhibitors across the spectrum of heart failure
21 May 2022
thumbnail
Congress Presentation
An algorithm for treatment of HFpEF and obesity: SGLT2i? GLP-1RA? or both?
13 May 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources